Hesse's Minister President visits CSL's R&D Campus
On a campus tour, young talents from research and development gave insights into recent biomedical innovations
Rejecting Life in a Bubble
CSL partnered with industry and advocacy organizations in Germany to create a bold, visual demonstration of why primary immun…
Gene therapy for Hemophilia B available
HEMGENIX® for patients with severe and moderate Hemophilia B now available in Germany
April 17 is World Haemophilia Day!
Access for All: Prevention of bleeds as the global standard of care
Alpha1 Science Awards
This year’s Alpha1 Science Awards winners announced at the Annual Meeting of the German Respiratory Society
Scholarship for talented students
With our sustainable strategy in our Early Career Programs, we attract and develop potential future leaders for CSL Behring.
“Phoenix” delivers on our promise
The new base fractionation in Marburg starts regular operation with a ceremonial opening.
Phase 3 Data on Garadacimab for HAE in Lancet
Significant reduction in number of attacks support the potential of once-monthly garadacimab as a prophylactic therapy for pa…